ETC
VOR icon

Exchange Traded Concepts’s Vor Biopharma VOR Stock Holding History

Exchange Traded Concepts’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,404
Closed -$106K – 1513
2025
Q1 		$106K Sell
7,404
-886
-11% -$21.3K ﹤0.01% 1140
2024
Q4 		$184K Hold
8,290
– – ﹤0.01% 1010
2024
Q3 		$116K Buy
8,290
+2,401
+41% +$43.8K ﹤0.01% 1120
2024
Q2 		$118K Sell
5,889
-1,833
-24% -$59.3K ﹤0.01% 931
2024
Q1 		$366K Buy
7,722
+4,713
+157% +$207K 0.01% 719
2023
Q4 		$135K Buy
3,009
+763
+34% +$31.5K ﹤0.01% 843
2023
Q3 		$95.2K Buy
2,246
+869
+63% +$47.1K ﹤0.01% 912
2023
Q2 		$85.1K Buy
+1,377
New +$126K ﹤0.01% 963

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Exchange Traded Concepts's VOR Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Vor Biopharma (VOR) in Q2 2025, closing a stake of 7,404 shares — an estimated $106K sold.

Exchange Traded Concepts first reported a position in VOR in Q2 2023 and held it in 8 quarters. The position peaked at $366K in Q1 2024. 35 funds tracked by Wall St. Rank hold VOR as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Vor Biopharma position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 7,404 Vor Biopharma shares in Q2 2025, an estimated $106K.
  • Exchange Traded Concepts first reported a position in Vor Biopharma in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Vor Biopharma position peaked at $366K in Q1 2024.
  • 35 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.